SofWave Medical Ltd.

Symbol: SOFW.TA

TLV

1910

ILA

Market price today

  • -13.2776

    P/E Ratio

  • 20.1481

    PEG Ratio

  • 652.47M

    MRK Cap

  • 0.00%

    DIV Yield

SofWave Medical Ltd. (SOFW-TA) Stock Price & Analysis

Shares Outstanding

34.16M

Gross Profit Margin

0.74%

Operating Profit Margin

-0.30%

Net Profit Margin

-0.30%

Return on Assets

-0.32%

Return on Equity

-0.45%

Return on Capital Employed

-0.48%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Louis Scafuri
Full-time employees:117
City:Yokneam Illit
Address:Hatavor 0
IPO:2021-05-18
CIK:

Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.

General Outlook

In simple terms, SofWave Medical Ltd. has 34.16 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.737% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.300%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.300%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.316% return, is a testament to SofWave Medical Ltd.'s adeptness in optimizing resource deployment. SofWave Medical Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.451%. Furthermore, the proficiency of SofWave Medical Ltd. in capital utilization is underscored by a remarkable -0.478% return on capital employed.

Stock Prices

SofWave Medical Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1895, while its low point bottomed out at $1871. This variance in figures offers investors a lucid insight into the roller-coaster ride that is SofWave Medical Ltd.'s stock market.

Liquidity Ratios

Analyzing SOFW.TA liquidity ratios reveals its financial health of the firm. The current ratio of 270.11% gauges short-term asset coverage for liabilities. The quick ratio (220.58%) assesses immediate liquidity, while the cash ratio (176.12%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio270.11%
Quick Ratio220.58%
Cash Ratio176.12%

Profitability Ratios

SOFW.TA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -29.97% underscores its earnings before tax deductions. The effective tax rate stands at -2.94%, revealing its tax efficiency. The net income per EBT, 100.00%, and the EBT per EBIT, 99.76%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -30.05%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-29.97%
Effective Tax Rate-2.94%
Net Income per EBT100.00%
EBT per EBIT99.76%
EBIT per Revenue-30.05%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.70, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 704.60% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding221
Days of Inventory Outstanding143
Operating Cycle194.35
Days of Payables Outstanding171
Cash Conversion Cycle23
Receivables Turnover7.05
Payables Turnover2.13
Inventory Turnover2.56
Fixed Asset Turnover12.39
Asset Turnover1.06

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.35, and free cash flow per share, -0.36, depict cash generation on a per-share basis. The cash per share value, 0.71, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.28, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.35
Free Cash Flow per Share-0.36
Cash per Share0.71
Operating Cash Flow Sales Ratio-0.28
Free Cash Flow to Operating Cash Flow Ratio1.03
Capital Expenditure Coverage Ratio-30.15
Dividend Paid and Capex Coverage Ratio-30.15

Debt and Leverage Ratios

An interest coverage of -38.64 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage-38.64
Company Equity Multiplier1.56

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.47, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.24, reflects the portion of profit attributed to each share. The book value per share, 0.77, represents the net asset value distributed per share, while the tangible book value per share, 0.77, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.47
Net Income Per Share-0.24
Book Value Per Share0.77
Tangible Book Value Per Share0.77
Shareholders Equity Per Share0.77
Interest Debt Per Share0.04
Capex Per Share-0.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 41.22%, indicates top-line expansion, while the gross profit growth, 42.34%, reveals profitability trends. EBIT growth, 53.92%, and operating income growth, 53.92%, offer insights into operational profitability progression. The net income growth, 57.61%, showcases bottom-line expansion, and the EPS growth, 57.89%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth41.22%
Gross Profit Growth42.34%
EBIT Growth53.92%
Operating Income Growth53.92%
Net Income Growth57.61%
EPS Growth57.89%
EPS Diluted Growth57.89%
Weighted Average Shares Growth0.26%
Weighted Average Shares Diluted Growth0.26%
Operating Cash Flow Growth41.03%
Free Cash Flow Growth39.75%
3-Year Revenue Growth per Share1058.28%
3-Year Operating CF Growth per Share-29.69%
3-Year Net Income Growth per Share30.03%
3-Year Shareholders Equity Growth per Share1597.45%
Receivables Growth-100.00%
Inventory Growth22.60%
Asset Growth-5.51%
Book Value per Share Growth-18.75%
Debt Growth-30.93%
R&D Expense Growth-8.14%
SGA Expenses Growth27.57%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 105,845,835.497, captures the company's total value, considering both debt and equity. Income quality, 0.76, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 22.71%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value105,845,835.497
Income Quality0.76
Sales General and Administrative to Revenue0.03
Research and Development to Revenue22.71%
Capex to Operating Cash Flow6.45%
Capex to Revenue-0.81%
Capex to Depreciation-27.04%
Stock-Based Compensation to Revenue4.53%
Graham Number2.05
Return on Tangible Assets-19.01%
Graham Net Net0.28
Working Capital23,351,000
Tangible Asset Value26,343,000
Net Current Asset Value22,577,000
Average Receivables2,295,500
Average Payables4,906,500
Average Inventory4,481,000
Days Payables Outstanding179
Days of Inventory On Hand140
ROIC-27.60%
ROE-0.31%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 6.54, and the price to book ratio, 6.54, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.98, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -13.84, and price to operating cash flows, -14.30, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio6.54
Price to Book Ratio6.54
Price to Sales Ratio3.98
Price Cash Flow Ratio-14.30
Price Earnings to Growth Ratio20.15
Enterprise Value Multiple-17.17
Price Fair Value6.54
Price to Operating Cash Flow Ratio-14.30
Price to Free Cash Flows Ratio-13.84
Price to Tangible Book Ratio4.89
Enterprise Value to Sales2.10
Enterprise Value Over EBITDA-16.01
EV to Operating Cash Flow-16.78
Earnings Yield-6.42%
Free Cash Flow Yield-5.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of SofWave Medical Ltd. (SOFW.TA) on the TLV in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -13.278 in 2024.

What is the ticker symbol of SofWave Medical Ltd. stock?

The ticker symbol of SofWave Medical Ltd. stock is SOFW.TA.

What is company IPO date?

IPO date of SofWave Medical Ltd. is 2021-05-18.

What is company current share price?

Current share price is 1910.000 ILA.

What is stock market cap today?

The market cap of stock today is 652465550.000.

What is PEG ratio in 2024?

The current 20.148 is 20.148 in 2024.

What is the number of employees in 2024?

In 2024 the company has 117.